Bayer takes €9.25 billion writedown Bayer took impairment charges of €9.25 billion and said the costs of its settlement over claims its Roundup weedkiller causes cancer would be higher as ... Business • 03 Nov 20
Bayer buys UK-based biotech KaNDy Therapeutics Bayer has agreed to acquire British biotech firm KaNDy Therapeutics for an initial $425 million, to strengthen its women's healthcare business with a prospective non-hormonal ... Business • 11 Aug 20
Bayer agrees to pay $10.9bn to settle Roundup claims Bayer has agreed to settle thousands of US lawsuits claiming that its widely-used weed killer Roundup caused cancer for as much as $10.9 billion after ... Business • 24 Jun 20
Bayer makes progress in settlement talks over Roundup Bayer said today it had made progress seeking a settlement over claims its glyphosate-based Roundup weedkiller causes cancer, after Bloomberg reported the company reached a ... Business • 25 May 20
Bayer more stringent in glyphosate settlement talks Bayer said the economic downturn and the need to preserve cash means it is taking a tougher stance in talks to settle claims its glyphosate-based ... Business • 27 Apr 20
EU bans Bayer pesticide linked to harming bees The European Commission has today decided not to renew approval for a pesticide linked to harming bees, effectively banning Bayer's insecticide known as thiacloprid. Business • 13 Jan 20
Number of glyphosate plaintiffs jumps to 42,700 - Bayer Bayer said the number of US plaintiffs blaming its glyphosate-based weedkillers for their cancer mushroomed to 42,700 from 18,400 in July, raising the stakes in ... Business • 30 Oct 19
Lanxess, Bayer sell chemical park operator to Macquarie German chemical groups Bayer and Lanxess have agreed to sell integrated chemical site operator Currenta to Macquarie Infrastructure and Real Assets for an enterprise value ... Business • 07 Aug 19
Bayer facing 18,400 US cases over glyphosate German pharmaceutical giant Bayer has said it is now targetted in some 18,400 US legal cases over glyphosate, a key herbicide ingredient that plaintiffs say ... Business • 30 Jul 19
US judge slashes Roundup jury award to $25.3m A federal judge has cut a damages award Bayer owed a California man who blamed Roundup weed killer for his cancer, to $25.27m from $80.27m. Business • 16 Jul 19
Bayer to invest €5 billion in new weedkillers Bayer, the German crop science and chemicals group reeling from US litigation over claims its glyphosate pesticide causes cancer, said it would invest €5 billion ... Business • 14 Jun 19
Bayer stock falls on $2 billion award in Roundup trial Shares in Bayer were down 5.9% today after a jury awarded more than $2 billion to a California couple in the largest US jury verdict ... Business • 14 May 19
Bayer gets Monsanto profit boost but legal burden grows German drug and farming supplies company Bayer has today posted a 45% gain in quarterly core earnings thanks to the acquisition of seed maker Monsanto. Business • 25 Apr 19
Five things to know about Bayer and Monsanto The second cancer victim in a year to win a surprise victory against US pesticide maker Monsanto raises the prospect of a flood of similar ... Business • 20 Mar 19
Investors flee Bayer after second Roundup trial blow The threat to German chemical giant Bayer and subsidiary Monsanto from US litigation swelled today, when its share price plunged after a jury ruled weedkiller ... Business • 20 Mar 19
France bans weed-killer after court ruling French authorities have banned the sale of a form of controversial weed-killer Roundup following a court ruling that regulators failed to take safety concerns into ... Europe • 15 Jan 19
US judge upholds Monsanto verdict but slashes award A US judge has upheld a jury verdict against Bayer subsidiary Monsanto in a historic case regarding the cancer danger of some of its weed ... World • 23 Oct 18
Germany advises drug makers to examine supply chain German drug makers have been asked by the government to examine their supply chains for any vulnerability that could cause shortages of essential drugs in ... Business • 29 Aug 18
Bayer shares plunge 14% after Roundup cancer trial Shares in Bayer have plunged more than 14% to their lowest in almost five years - wiping around $14 billion off the value of the ... Business • 13 Aug 18
Russian nod moves Bayer closer to Monsanto deal Russia's competition regulator FAS has approved Bayer's planned takeover of Monsanto, the German drugs and crop chemicals maker said, as it enters the home stretch ... Business • 20 Apr 18
Bayer reaches deal with US for approval to buy Monsanto The US Justice Department will allow German drugs and pesticides group Bayer to acquire Monsanto in a $62.5 billion deal, according to US media reports. Business • 10 Apr 18
Bayer wins EU approval for $62.5 billion Monsanto buy German conglomerate Bayer has today won EU competition approval for its $62.5 billion buy of US peer Monsanto, the latest in a trio of mega ... Business • 21 Mar 18
Bayer to win EU approval for $62 billion Monsanto deal German drug and crop chemicals maker Bayer is set to win conditional European Union competition approval for its $62.5 billion bid for the world's biggest ... Business • 28 Feb 18
BASF to buy seeds, herbicide businesses from Bayer BASF has agreed to buy significant parts of Bayer's seed and herbicide businesses for €5.9 billion in cash, the two companies said today. Business • 13 Oct 17
Monsanto profit tops expectations on soybean sales Seeds and agrochemicals company Monsanto, which is being bought by Germany's Bayer, reported a stronger-than-expected quarterly profit as record US and Brazilian soybean plantings lifted ... Business • 28 Jun 17
